Form D · Pharmaceuticals

FIBROGEN INC

San Francisco, CA · CIK 0000921299

Offering snapshot reported Dec 10, 2014 · SEC filing

Reported sold
$20M
Offering amount: $20M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 19, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 10, 2014Initial$20,000,000No comparison1SEC filing
Apr 11, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jan 10, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Apr 14, 2006PaperNot reportedNo comparisonNot reported
Nov 23, 2005PaperNot reportedNo comparisonNot reportedSEC filing
Jan 18, 2005PaperNot reportedNo comparisonNot reported

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-229821

Source: Form D, filed Dec 10, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Pat Cotroneo Executive
Thomas F. Kearns Director
Kalevi Kurkijarvi Director
Miguel Madero Director
Thomas B. Neff Director, Executive
Rory B. Riggs Director
Roberto Pedro Rosenkranz Director
Jorma Routti Director
James A. Schoeneck Director
Julian N. Stern Director
Toshinari Tamura Director
Frank H. Valone Executive
K. Peony Yu Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
409 Illinois Street
San Francisco, CA, 94158